This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verhaeghe, J. Articles by Igout, A. Search for Related Content PubMed PubMed Citation Articles by Verhaeghe, J. Articles by Igout, A.

Placental GH, IGF-I, IGF-Binding Protein-1, and Leptin during a Glucose Challenge Test in Pregnant Women: Relation with Maternal Body Weight, Glucose Tolerance, and Birth Weight

Department of Obstetrics and Gynecology (J.V.), and Laboratorium voor Experimentele Geneeskunde en Endocrinologie (J.V., E.V.H.), Katholieke Universiteit Leuven, 3000 Leuven, Belgium; and Département Universitaire de Gynécologie-Obstétrique, Centre Hospitalier de la Citadelle, and Laboratoire de Biologie des Tumeurs et du Développement (A.P., J.-M.F.), and Laboratoire d’Endocrinologie, Service de Biochimie (G.H., A.I.), Université de Liège, 4000 Liège, Belgium

Address all correspondence to: J. Verhaeghe, M.D., Department of Obstetrics and Gynecology, U. Z. Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. E-mail: . johan.verhaeghe{at}uz.kuleuven.ac.be

Abstract

The prediction of birth weight may be improved by the measurement of hormones or growth factors in the mother. We measured body weight (BW) and plasma levels of placental GH (PGH), IGF-I, IGF-binding protein-1 (IGFBP-1), and leptin at the time of the glucose challenge test (GCT) in 289 women, who were pregnant with a single fetus, between 24 and 29 wk gestational age (GA). Delivery occurred 12 ± 2 (mean ± SD) wk later.

First, we examined which variables regulate these hormonal factors. Multiple regression showed that PGH concentrations were determined by GA at sampling and were negatively related to BW. IGF-I levels were mainly determined by PGH, and also by insulin, BW, and (negatively) age. IGFBP-1 concentrations were negatively determined by BW, insulin, and IGF-I. BW was also a powerful determinant of leptin levels, with insulin as a less robust determinant.

Second, we examined the relation to glucose levels. PGH, IGF-I, and IGFBP-1 concentrations were not correlated with post-GCT glucose levels and were comparable in women with a normal or disturbed GCT (glucose 7.8 mmol/liter; n = 72).

Finally, we examined the relation with birth weight and placental weight. Birth weight, corrected for GA and stratified into percentile groups, and the ponderal index at birth were strongly related to maternal BW, but not to maternal PGH, IGF-I, or IGFBP-1 levels. Neither was maternal leptin related to birth weight, but leptin concentrations were slightly higher in women who delivered obese babies. Placental weight was not related to any of the hormonal factors.

This prospective study indicates that the variation in circulating PGH, IGF-I, IGFBP-1, and leptin between 24 and 29 wk of pregnancy is strongly dependent on maternal BW, but is unrelated to glucose tolerance. In addition, the measurement of PGH, IGF-I, IGFBP-1, or leptin at the time of the GCT is not useful clinically to predict birth weight.

This article has been cited by other articles:

				W Ricart, J Lopez, J Mozas, A Pericot, M A Sancho, N Gonzalez, M Balsells, R Luna, A Cortazar, P Navarro, et al. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses J Epidemiol Community Health, January 1, 2009; 63(1): 64 - 68. [Abstract] [Full Text] [PDF]

				R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]

				P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				J. Fuglsang, P. Sandager, N. Moller, S. Fisker, H. Orskov, and P. Ovesen Kinetics and secretion of placental growth hormone around parturition. Eur. J. Endocrinol., March 1, 2006; 154(3): 449 - 457. [Abstract] [Full Text] [PDF]

				T Clausen, T K Burski, N Oyen, K Godang, J Bollerslev, and T Henriksen Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study Eur. J. Endocrinol., December 1, 2005; 153(6): 887 - 894. [Abstract] [Full Text] [PDF]

				J. Verhaeghe, R. van Bree, E. van Herck, and W. Coopmans Exogenous Corticosteroids and in Utero Oxygenation Modulate Indices of Fetal Insulin Secretion J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3449 - 3453. [Abstract] [Full Text] [PDF]

				M. Chellakooty, K. Vangsgaard, T. Larsen, T. Scheike, J. Falck-Larsen, J. Legarth, A. M. Andersson, K. M. Main, N. E. Skakkebaek, and A. Juul A Longitudinal Study of Intrauterine Growth and the Placental Growth Hormone (GH)-Insulin-Like Growth Factor I Axis in Maternal Circulation: Association between Placental GH and Fetal Growth J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 384 - 391. [Abstract] [Full Text] [PDF]

				J. Fuglsang, F. Lauszus, A. Flyvbjerg, and P. Ovesen Erratum J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5042 - 5042. [Abstract] [Full Text] [PDF]

				J. Fuglsang, F. Lauszus, A. Flyvbjerg, and P. Ovesen Human Placental Growth Hormone, Insulin-Like Growth Factor I and -II, and Insulin Requirements during Pregnancy in Type 1 Diabetes J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4355 - 4361. [Abstract] [Full Text] [PDF]

				Z. Wu, M. Bidlingmaier, S. C. Friess, S. E. Kirk, P. Buchinger, B. Schiessl, and C. J. Strasburger A New Nonisotopic, Highly Sensitive Assay for the Measurement of Human Placental Growth Hormone: Development and Clinical Implications J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 804 - 811. [Abstract] [Full Text] [PDF]